Moisés Galindo

Scientist 🔬📝🎶☕🍔🍟🍺 solo 1 humano más entre casi 8000000000 de humanos…que viven en 1 planeta de miles en un universo infinito

[El Colegio Nacional @ColegioNal_mx]

El #LUNES sintoniza una conferencia #VIRTUAL para conocer uno de los ámbitos más sorprendentes y menos conocidos de la diversidad viral.

🗓 Lunes 28 de septiembre · 18 h
🌐 ACTIVIDAD VIRTUAL
🎙 Coordina: @profsuslopez
👥 Participan: Jônatas Abrahão (Departamento de Microbiología-@ufmg, Brasil) y Natalia Ramos (Instituto de Biología de la @FcienUdelar, Uruguay)

👉 https://t.co/bB3bjoS086

#LibertadPorElSaber @CoViGenMex @Viro_ConacytMX @fciencias @UNAMPUIREE @inmegen @IPNENCB

[Moisés Galindo @mrzimogeno]

https://t.co/nUfaQWuqcF

[ASM @ASMicrobiology]

The endoplasmic reticulum (ER) is a big, important organelle. But what is its role in filamentous fungi (i.e., hyphae)? Information is limited, though this #MMBR review provides some insights and identifies knowledge gaps that must be resolved. https://t.co/KIcMEn6zQZ

[Cedric🧬➰🧬Feschotte @CedricFeschotte]

A genetic element aka a transposable element. Just say it ffs!! 😜🐒
https://t.co/JqoNVJMem8

[ASM @ASMicrobiology]

In #JVirology, researchers find that collateral sensitivity—when resistance to 1 antimicrobial agent increases sensitivity to another—bolsters the efficacy of a rationally designed phage combination to control the foodborne pathogen Salmonella enterica. https://t.co/AGljo6xGiW

[Moisés Galindo @mrzimogeno]

https://t.co/FasyibCbwk

[Moisés Galindo @mrzimogeno]

https://t.co/pU4lknHSD7

[ASM @ASMicrobiology]

With a novel mechanism of action & no known resistances, peptidoglycan hydrolases (PGH) show promise as antimicrobials. In @mbiojournal, researchers engineered a PGH that exhibits an extraordinary ability to eradicate staphylococci. https://t.co/Ab4H6XGySj

[Gnome Anne May Perceive Me @annethegnome]

FUNGUS IN SPACE!!! 🍄🚀

Equal parts cosmic horror and nature being metal, let's talk about the lichen that grew on the OUTSIDE of the International Space Station!

Get your tea and curl up, because I PROMISE you wanna hear about these fungal cosmonauts 🧑‍🚀
🧵

[Moisés Galindo @mrzimogeno]

https://t.co/L1i0RHUESg

[Shai Bel @Mucus_Man]

🚨🚨I'm excited to share our new paper out now in @PLOSBiology! We found that Salmonella tricks us into killing its competitors, the gut microbiota, by inducing IL-1b production. This allows Salmonella to remodel the gut niche to it's advantage. A 🧵/1
https://t.co/3o1hPjhfiV

[Moisés Galindo @mrzimogeno]

😍

[Smart Biology @SmartBiology3D]

Understanding biology means seeing the unseeable. We help students do this, by integrating all available data from across the literature, to produce stunning visualizations of biological processes.
Learn more at https://t.co/rZjuFXgP1n
#biology #3D #science #EdTech #animation

[Moisés Galindo @mrzimogeno]

https://t.co/FQnh5d0xrm

[Moisés Galindo @mrzimogeno]

https://t.co/3ri3Y4Fkcz

[UNAM @UNAM_MX]

Consulta el nuevo número de @Gaceta_UNAM > https://t.co/vlkpDHMYm5

[Moisés Galindo @mrzimogeno]

https://t.co/u4cMyVrJj2

[ASM @ASMicrobiology]

Since 2010, the genus Listeria has had the addition of 22 new species. In @mbiojournal—a review of the taxonomy, ecology and relevance to food safety of these species, plus a re-iteration of the suggestion to re-classify some of them into new genera. https://t.co/66GrsWvMj8

[Dennis X. Hu @DennisWhom]

2023 Small Molecule Approvals! @drughuntersite

A lot of fascinating firsts in 2023 including:

-The first FDA-approved oral ER degrader
-The first FDA-approved reversible BTK inhibitor
-The first FDA-approved gamma-secretase inhibitor (not in Alzheimer’s!)
-A reversible covalent, brain-penetrant Nrf2 activator
-The first drug derived from mRNA display screening for macrocyclic peptides
-The first PI3K inhibitor with a first approval outside oncology
-A factor B-targeting Breakthrough Therapy for paroxysmal nocturnal hemoglobinuria
-The first intranasal CGRP antagonist for fast-acting migraine treatment

Full Open Access article + hi-res poster here:
https://t.co/Q3rXkwMBp9

[Moisés Galindo @mrzimogeno]

"The threat of antimicrobial resistance means that new antibiotics need to be used sparingly. Governments must support their development with a long-term funding plan" https://t.co/p0fy9amyU3